EGFR and non-small cell lung carcinoma: In addition, we determined the antiproliferative activity of DBG in the NSCLC cells pretreated with NAC, an inhibitor of cellular ROS, by analyzing the viability of cells and the phosphorylation levels of EGFR, MET, and AKT.